Related Experiment Video
Updated: May 30, 2026

Mapping the Structure-Function Relationships of Disordered Oncogenic Transcription Factors Using Transcriptomic Analysis
Published on: June 27, 2020
Androgen regulation of ETS gene fusion transcripts in prostate cancer
1Department of Pathology, Josephine Nefkens Institute, Erasmus University Medical Centre, Rotterdam, The Netherlands. d.gasi@erasmusmc.cl
Abstract:
Fusion between androgen-regulated TMPRSS2 and ETS transcription factor gene ERG is the most frequent genetic alteration that occurs in 40-70% of prostate cancers. Not only ERG but also other ETS transcription factor genes are involved in gene fusions. ETV1, ETV4, and ETV5 have all several fusion partners. One common feature shared by the majority of these partners is androgen-regulated expression. Despite its high frequency, the biological and molecular effects of ETS gene fusion in prostate cancer development and progression are unknown. In this chapter quantitative polymerase chain reaction (Q-PCR) is used for detection and further studying the incidence and properties of these fusion transcripts. The focus is on the expression of TMPRSS2-ERG transcripts in clinical prostate samples. Androgen regulation of TMPRSS2 is measured in commonly used LNCaP prostate cancer cells grown with and without the synthetic androgen R1881. Furthermore, combining Q-PCR with 5' RLM-RACE and sequencing are described for the identification of novel ETS fusion partners.
Insights
TMPRSS2-ERG gene fusions are common in prostate cancer. This study uses quantitative polymerase chain reaction (Q-PCR) to detect these fusions and investigate their androgen regulation, aiding in understanding their role in cancer.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- TMPRSS2-ERG gene fusion is the most frequent genetic alteration in prostate cancer, occurring in 40-70% of cases.
- Other ETS transcription factor genes (ETV1, ETV4, ETV5) are also involved in gene fusions with androgen-regulated partners.
- The biological and molecular effects of ETS gene fusions in prostate cancer remain largely unknown.
Purpose of the Study:
- To detect and study the incidence and properties of ETS gene fusion transcripts in prostate cancer.
- To investigate the androgen regulation of TMPRSS2 expression in prostate cancer cells.
- To identify novel ETS fusion partners using advanced molecular techniques.
Main Methods:
- Quantitative polymerase chain reaction (Q-PCR) for detection and quantification of fusion transcripts.
- Culturing LNCaP prostate cancer cells with and without synthetic androgen R1881 to measure TMPRSS2 androgen regulation.
- Combining Q-PCR with 5' RLM-RACE and sequencing for novel fusion partner identification.
Main Results:
- Focus on the expression of TMPRSS2-ERG transcripts in clinical prostate samples.
- Measurement of androgen regulation of TMPRSS2 in LNCaP cells.
- Methodology established for identifying novel ETS fusion partners.
Conclusions:
- Q-PCR is a valuable tool for studying ETS gene fusions in prostate cancer.
- Understanding androgen regulation of fusion genes is crucial for prostate cancer research.
- Further research is needed to elucidate the biological significance of ETS gene fusions.
Related Concept Videos
Mitogens and the Cell Cycle
Abnormal Proliferation

